Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep 15;202(6):793-794.
doi: 10.1164/rccm.202006-2144ED.

Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention

Anthony T Podany  1
Affiliations
Editorial

Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention

Anthony T Podany. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Hibma JE, Radtke KK, Dorman SE, Jindani A, Dooley KE, Weiner M, et al. Rifapentine population pharmacokinetics and dosing recommendations for latent tuberculosis infection Am J Respir Crit Care Med 2020202866–877.. - PMC - PubMed
    1. Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155–2166. - PubMed
    1. Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, et al. BRIEF TB/A5279 Study Team. One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. N Engl J Med. 2019;380:1001–1011. - PMC - PubMed
    1. Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, et al. International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169:247–255. - PMC - PubMed
    1. Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger N, Muzanyi G, et al. Tuberculosis Trials Consortium. Daily rifapentine for treatment of pulmonary tuberculosis: a randomized, dose-ranging trial. Am J Respir Crit Care Med. 2015;191:333–343. - PMC - PubMed